These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 37181377)

  • 1. Idiopathic pulmonary fibrosis and the role of genetics in the era of precision medicine.
    Alonso-Gonzalez A; Tosco-Herrera E; Molina-Molina M; Flores C
    Front Med (Lausanne); 2023; 10():1152211. PubMed ID: 37181377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary fibrosis in the era of stratified medicine.
    Mathai SK; Newton CA; Schwartz DA; Garcia CK
    Thorax; 2016 Dec; 71(12):1154-1160. PubMed ID: 27799632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study.
    Dressen A; Abbas AR; Cabanski C; Reeder J; Ramalingam TR; Neighbors M; Bhangale TR; Brauer MJ; Hunkapiller J; Reeder J; Mukhyala K; Cuenco K; Tom J; Cowgill A; Vogel J; Forrest WF; Collard HR; Wolters PJ; Kropski JA; Lancaster LH; Blackwell TS; Arron JR; Yaspan BL
    Lancet Respir Med; 2018 Aug; 6(8):603-614. PubMed ID: 29891356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics in Idiopathic Pulmonary Fibrosis Pathogenesis, Prognosis, and Treatment.
    Kaur A; Mathai SK; Schwartz DA
    Front Med (Lausanne); 2017; 4():154. PubMed ID: 28993806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis.
    Finnerty JP; Ponnuswamy A; Dutta P; Abdelaziz A; Kamil H
    BMC Pulm Med; 2021 Dec; 21(1):411. PubMed ID: 34895203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Rare Missense Variant in Telomerase Reverse Transcriptase is Associated with Idiopathic Pulmonary Fibrosis in a Chinese Han Family.
    Zheng CM; Zhan X; Yang YH; Jiang T; Ye Q; Lu Y
    Chin Med J (Engl); 2018 Sep; 131(18):2205-2209. PubMed ID: 30203795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of immune response in the pathogenesis of idiopathic pulmonary fibrosis: far beyond the Th1/Th2 imbalance.
    Spagnolo P; Tonelli R; Samarelli AV; Castelli G; Cocconcelli E; Petrarulo S; Cerri S; Bernardinello N; Clini E; Saetta M; Balestro E
    Expert Opin Ther Targets; 2022 Jul; 26(7):617-631. PubMed ID: 35983984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosis.
    Yoshikawa T; Otsuka M; Chiba H; Ikeda K; Mori Y; Umeda Y; Nishikiori H; Kuronuma K; Takahashi H
    BMC Pulm Med; 2020 Jan; 20(1):27. PubMed ID: 32005219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic Pulmonary Fibrosis Is Associated with Common Genetic Variants and Limited Rare Variants.
    Peljto AL; Blumhagen RZ; Walts AD; Cardwell J; Powers J; Corte TJ; Dickinson JL; Glaspole I; Moodley YP; Vasakova MK; Bendstrup E; Davidsen JR; Borie R; Crestani B; Dieude P; Bonella F; Costabel U; Gudmundsson G; Donnelly SC; Egan J; Henry MT; Keane MP; Kennedy MP; McCarthy C; McElroy AN; Olaniyi JA; O'Reilly KMA; Richeldi L; Leone PM; Poletti V; Puppo F; Tomassetti S; Luzzi V; Kokturk N; Mogulkoc N; Fiddler CA; Hirani N; Jenkins RG; Maher TM; Molyneaux PL; Parfrey H; Braybrooke R; Blackwell TS; Jackson PD; Nathan SD; Porteous MK; Brown KK; Christie JD; Collard HR; Eickelberg O; Foster EE; Gibson KF; Glassberg M; Kass DJ; Kropski JA; Lederer D; Linderholm AL; Loyd J; Mathai SK; Montesi SB; Noth I; Oldham JM; Palmisciano AJ; Reichner CA; Rojas M; Roman J; Schluger N; Shea BS; Swigris JJ; Wolters PJ; Zhang Y; Prele CMA; Enghelmayer JI; Otaola M; Ryerson CJ; Salinas M; Sterclova M; Gebremariam TH; Myllärniemi M; Carbone RG; Furusawa H; Hirose M; Inoue Y; Miyazaki Y; Ohta K; Ohta S; Okamoto T; Kim DS; Pardo A; Selman M; Aranda AU; Park MS; Park JS; Song JW; Molina-Molina M; Planas-Cerezales L; Westergren-Thorsson G; Smith AV; Manichaikul AW; Kim JS; Rich SS; Oelsner EC; Barr RG; Rotter JI; Dupuis J; O'Connor G; Vasan RS; Cho MH; Silverman EK; Schwarz MI; Steele MP; Lee JS; Yang IV; Fingerlin TE; Schwartz DA
    Am J Respir Crit Care Med; 2023 May; 207(9):1194-1202. PubMed ID: 36602845
    [No Abstract]   [Full Text] [Related]  

  • 10. Update on therapeutic management of idiopathic pulmonary fibrosis.
    Tzouvelekis A; Bonella F; Spagnolo P
    Ther Clin Risk Manag; 2015; 11():359-70. PubMed ID: 25767391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis.
    Moore C; Blumhagen RZ; Yang IV; Walts A; Powers J; Walker T; Bishop M; Russell P; Vestal B; Cardwell J; Markin CR; Mathai SK; Schwarz MI; Steele MP; Lee J; Brown KK; Loyd JE; Crapo JD; Silverman EK; Cho MH; James JA; Guthridge JM; Cogan JD; Kropski JA; Swigris JJ; Bair C; Kim DS; Ji W; Kim H; Song JW; Maier LA; Pacheco KA; Hirani N; Poon AS; Li F; Jenkins RG; Braybrooke R; Saini G; Maher TM; Molyneaux PL; Saunders P; Zhang Y; Gibson KF; Kass DJ; Rojas M; Sembrat J; Wolters PJ; Collard HR; Sundy JS; O'Riordan T; Strek ME; Noth I; Ma SF; Porteous MK; Kreider ME; Patel NB; Inoue Y; Hirose M; Arai T; Akagawa S; Eickelberg O; Fernandez IE; Behr J; Mogulkoc N; Corte TJ; Glaspole I; Tomassetti S; Ravaglia C; Poletti V; Crestani B; Borie R; Kannengiesser C; Parfrey H; Fiddler C; Rassl D; Molina-Molina M; Machahua C; Worboys AM; Gudmundsson G; Isaksson HJ; Lederer DJ; Podolanczuk AJ; Montesi SB; Bendstrup E; Danchel V; Selman M; Pardo A; Henry MT; Keane MP; Doran P; Vašáková M; Sterclova M; Ryerson CJ; Wilcox PG; Okamoto T; Furusawa H; Miyazaki Y; Laurent G; Baltic S; Prele C; Moodley Y; Shea BS; Ohta K; Suzukawa M; Narumoto O; Nathan SD; Venuto DC; Woldehanna ML; Kokturk N; de Andrade JA; Luckhardt T; Kulkarni T; Bonella F; Donnelly SC; McElroy A; Armstong ME; Aranda A; Carbone RG; Puppo F; Beckman KB; Nickerson DA; Fingerlin TE; Schwartz DA
    Am J Respir Crit Care Med; 2019 Jul; 200(2):199-208. PubMed ID: 31034279
    [No Abstract]   [Full Text] [Related]  

  • 12. Precision medicine in idiopathic pulmonary fibrosis therapy: From translational research to patient-centered care.
    Antoniou KM; Tsitoura E; Vasarmidi E; Symvoulakis EK; Aidinis V; Tzilas V; Tzouvelekis A; Bouros D
    Curr Opin Pharmacol; 2021 Apr; 57():71-80. PubMed ID: 33556824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis.
    Allen RJ; Guillen-Guio B; Oldham JM; Ma SF; Dressen A; Paynton ML; Kraven LM; Obeidat M; Li X; Ng M; Braybrooke R; Molina-Molina M; Hobbs BD; Putman RK; Sakornsakolpat P; Booth HL; Fahy WA; Hart SP; Hill MR; Hirani N; Hubbard RB; McAnulty RJ; Millar AB; Navaratnam V; Oballa E; Parfrey H; Saini G; Whyte MKB; Zhang Y; Kaminski N; Adegunsoye A; Strek ME; Neighbors M; Sheng XR; Gudmundsson G; Gudnason V; Hatabu H; Lederer DJ; Manichaikul A; Newell JD; O'Connor GT; Ortega VE; Xu H; Fingerlin TE; Bossé Y; Hao K; Joubert P; Nickle DC; Sin DD; Timens W; Furniss D; Morris AP; Zondervan KT; Hall IP; Sayers I; Tobin MD; Maher TM; Cho MH; Hunninghake GM; Schwartz DA; Yaspan BL; Molyneaux PL; Flores C; Noth I; Jenkins RG; Wain LV
    Am J Respir Crit Care Med; 2020 Mar; 201(5):564-574. PubMed ID: 31710517
    [No Abstract]   [Full Text] [Related]  

  • 14. Genomic Fingerprint Associated with Familial Idiopathic Pulmonary Fibrosis: A Review.
    Ding D; Gao R; Xue Q; Luan R; Yang J
    Int J Med Sci; 2023; 20(3):329-345. PubMed ID: 36860670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung transplantation for idiopathic pulmonary fibrosis enriches for individuals with telomere-mediated disease.
    Alder JK; Sutton RM; Iasella CJ; Nouraie M; Koshy R; Hannan SJ; Chan EG; Chen X; Zhang Y; Brown M; Popescu I; Veatch M; Saul M; Berndt A; Methé BA; Morris A; Pilewski JM; Sanchez PG; Morrell MR; Shapiro SD; Lindell KO; Gibson KF; Kass DJ; McDyer JF
    J Heart Lung Transplant; 2022 May; 41(5):654-663. PubMed ID: 34933798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of idiopathic pulmonary fibrosis: from mechanistic pathways to personalised medicine.
    Spagnolo P; Cottin V
    J Med Genet; 2017 Feb; 54(2):93-99. PubMed ID: 28011761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic pulmonary fibrosis.
    Koudstaal T; Wijsenbeek MS
    Presse Med; 2023 Sep; 52(3):104166. PubMed ID: 37156412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic pulmonary fibrosis: pathogenesis and management.
    Sgalla G; Iovene B; Calvello M; Ori M; Varone F; Richeldi L
    Respir Res; 2018 Feb; 19(1):32. PubMed ID: 29471816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Exome Sequencing Study to Assess the Role of Rare Genetic Variation in Pulmonary Fibrosis.
    Petrovski S; Todd JL; Durheim MT; Wang Q; Chien JW; Kelly FL; Frankel C; Mebane CM; Ren Z; Bridgers J; Urban TJ; Malone CD; Finlen Copeland A; Brinkley C; Allen AS; O'Riordan T; McHutchison JG; Palmer SM; Goldstein DB
    Am J Respir Crit Care Med; 2017 Jul; 196(1):82-93. PubMed ID: 28099038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candidate genes of idiopathic pulmonary fibrosis: current evidence and research.
    Zhou W; Wang Y
    Appl Clin Genet; 2016; 9():5-13. PubMed ID: 26893575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.